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Neutral endopeptidase 24.11 (EC 3.4.24.11; NEP) is a membrane-bound Zn-metalloendopeptidase with a catalytic activity and a specificity very 
similar to that of thermolysin, a bacterial zinc-endoprotease. NEP can be inactivated by reaction with diethylpyrocarbonate, due to the modification 
of a histidine residue present in the active site of the enzyme. This histidine residue was proposed to be analogous to Hisz3’ in thermolysin, which 
is involved in the stabilization of the tetrahedral intermediate during the transition state. Using site-directed mutagenesis of the cDNA encoding 
rabbit NEP, we have created two mutants of NEP where His”’ was replaced by either Gln or Phe (NEP-Cm” and NEP-Phe”‘). Determination 
of kinetic parameters howed that both mutants had K,,, values very similar to that of the non-mutated enzyme but that their k,, values were 25-fold 
lower. The calculated ifference in free energy needed to form the transition state complex was increased by 2.2 kcaVmo1 for both mutants. These 
observations trongly suggest hat His”’ IS involved in the stabilization of the transition state by forming an hydrogen bond with the oxyanion 
of the tetrahedral intermediate. 
Neutral endopeptidase; Catalytic mechanism; Transition state 
1. INTRODUCTION 
Neutral endopeptidase (EC 3.4.24.11, neprilysin, 
NEP) is a membrane-bound zinc-metalloendopeptidase 
present at the plasma membrane of many cell types. The 
complete primary structure of NEP had been deduced 
from the sequences of cDNA clones from rabbit [l], rat 
[2], human [3] and, recently, mouse [4]. This 94 kDa 
ectoenzyme contains 749 amino acid residues. The pro- 
tein has an NH,-terminal cytoplasmic domain of 27 
amino acid residues, an hydrophobic domain of 23 resi- 
dues that anchors the protein in the plasma membrane, 
and finally, a large extracellular domain that contains 
the active site [5]. 
Although NEP is approximately twice the size of 
thermolysin (TLN), a bacterial zinc-endoprotease, both 
exhibit similar specificity with regard to substrates and 
inhibitors. Indeed, both enzymes prefer bulky P’l resi- 
dues, such as phenylalanine and leucine, in the sequence 
of their substrates, and both enzymes are inhibited by 
phosphoramidon. Furthermore, residues involved in 
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zinc binding and in the acid/base catalysis are found in 
a similar sequence in both enzymes [6,7]. However, 
TLN and NEP react differently with the arginine-spe- 
cific reagents, butanedione and phenylglyoxal, suggest- 
ing differences in the active site of these enzymes. In- 
deed, it has been shown recently that two arginine resi- 
dues are involved in substrate binding in NEP [8,9] 
while X-ray diffraction studies showed only one argin- 
ine in the TLN active site [lo]. 
The proposed catalytic mechanism for TLN involves 
an attack of a water molecule on the carbonyl of the 
scissile bond to form an oxyanion, a tetrahedral inter- 
mediate which subsequently breaks down into products 
[11,12]. The stabilization of this transition state by en- 
zyme residues is crucial for catalysis. In TLN, X-ray 
diffraction studies indicated that the tetrahedral inter- 
mediate is stabilized by hydrogen bonding with Hisz3’ 
and Tyr15’ [l 11. In NEP an inactivation study with di- 
ethylpyrocarbonate (DEPC) suggested the presence in 
the active site of a histidine residue which is probably 
involved in the stabilization of the transition state 
[13,14]. Using photoaffinity labelling, Bateman et al. 
[ 151 have shown that His’l ’ of NEP could be crosslinked 
to N-bromoacetyl-D-leucylglycine, anirreversible inhib- 
itor of NEP which mimics the transition state of the 
catalytic reaction. Hence, they proposed that residue 
His”’ of NEP was present at the active site and could 
explain the sensitivity of this enzyme to DEPC. How- 
ever, mutations of this residue resulted in an inactive 
enzyme and no conclusion could be drawn as to its role 
in catalysis. 
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In the present study, we used site-directed mutagene- pSVENK19 described previously [6]. Vectors, 
sis of the cDNA encoding the NEP sequence and trans- pSVENKl9-Gln7” and pSVENK19-Phe”‘, and the 
fections of COS-1 cells to express mutated NEP en- pSVENKl9 carrying the non-mutated cDNA, were 
zymes in which the residue, His7”, was changed for 
either Gin or Phe (NEP-Gln7” and NEP-Phe”‘). 
used to transfect COS- 1 cells. Binding of Mab [‘251]2B 12 
as well as immunoblot analysis of proteins extracted 
Changes observed in the kinetic parameters of the mu- from transfected COS-1 cell membranes howed similar 
tant enzymes are consistent with a role of His’l’ in the levels of expression of mutated and non-mutated NEPs 
stabilization of the transition state during catalysis. (results not shown). 
2. EXPERIMENTAL 
2.1. Site-directed mutagenus and vector constructron 
All DNA manipulations were performed using described proce- 
dures 1161. Oligonucieotide-dir~t~ mutagenesis was performed ac- 
cording to the method described by Taylor et al. [17], with an Ml3 
subclone contaming the proper fragment of NEP cDNA. Recombi- 
nant M13-NEP phages carrying the mutations were screened irectly 
by DNA sequencing [18]. A DNA fragment containing the mutated 
region was isolated from the replicating form of the M13-NEP recom- 
binant phage and substituted for the equivalent non-mutated fragment 
in pSVENKl9, a previously described NEP expression vector [6]. The 
presence of the mutations in the expression vectors was confirmed by 
sequencing the mutated regions by the chain-termination method for 
double-stranded templates using T7 DNA polymerase 1191. 
2.2. Transfection of COS-I’ cells and hmding of f”‘I]ZB12 monoclonul 
untzbod? 
COS-1 cells [20] were transfected using the standard calcmm-phos- 
phate co-precipitation procedure [21] as previously described [22]. 
Two days after transfection, cells were harvested by scraping in Trts- 
buffered saline (TBS; 10 mM Tris, pH 7.4, 150 mM NaCl) with a 
rubber spatula. The bindmg of [“?]2Bl2 monoclonal antibody was 
performed as described prevtously [7], and was used to determine the 
relative amounts of NEP expressed at the cell surface. 
2.3. Enzyme assaw and rmmunoblott~~~g 
NEP from transfected COS-1 cells was solubilized in 50 mM MES- 
NaOH, pH 6.5, containing 1% octylglucoside and the enzymatic activ- 
tty was measured essentially as described previously [23] using 50 nM 
of the tritiated substrate [tyrosyl-(3.5-‘H)](o-Ala;)-Leu-Enkephalm 
(50 Wmmol) purchased from Commisariat a I’Energie Atomique 
(Gif-&r-Yvette, France), except hat incubations were carried out in 
50 mM MES-NaOH, pH 6.5, at 37°C. The I& values were determined 
by the isotopic dilution method. Calculattons were done using the 
program ENZFITER. In order to calculate the k,,, values, the 
amounts of enzyme were quantitated by immunoblot analysis using 
purified rabbit kidney NEP as standard [23]. Immunoblotting was 
performed as previously described using monoclonal antibody 18B5, 
which recognizes alinear epitope of the rabbit NEP sequence (Labonte 
and Crine, unpublished results). 
3.2. Enzymatic properties of mutated NEP 
It was hypothesized that since stabilization of the 
transition state is important for catalysis, mutation of 
one of the residues participating in this process would 
affect enzyme activity. To test the activity of mutated 
enzymes, we measured the rate of hydrolysis of the 
tritiated substrate (D-Ala,)-Leu-Enkephalin. Mutated 
enzymes exhibited an important decrease in activity 
(Fig. 1). Under initial velocity conditions, the activity of 
mutated NEPs was approximately 20-fold lower than 
that of the non-mutated enzyme. 
We next determined the kinetic parameters for non- 
mutated and mutated enzymes. The K, values for non- 
mutated NEP was 86 f 6 PM. Both mutants exhibited 
slightly higher K, values, 144 * 1.5 PM for NEP-Gln7” 
and 125 + 16 PM for NEP-Phe7” (Table I). This in- 
crease may correspond to a variation in the interaction 
of the mutated enzymes with the substrate. On the other 
hand, the k,, values for the mutants were 25-fold lower 
than that of the non-mutated NEP (Table I). Further- 
more, the difference in free energy between the reaction 
catalyzed by NEP-Gln7” or NEP-Phe7” and non-mu- 
tated NEP (MC) calculated from k,,,lK, values [24], 
was found to be 2.2 kcal/mol for both mutated enzymes 
(Table I). 
‘00 - 0 Non-mutated NEP 





2.4. InactivatIon ofh’EP with DEPC 
The enzymes were dissolved m 50 mM MES-NaOH. pH 6.5, con- 
taining 1% octylglucoside. DEPC previously diluted m 70% ethanol, 
was added to the final concentrations indicated. The reactions were 
allowed to proceed at 25°C for 30 min and the enzyme activity was 
determined as described m section 2.3. 
3. RESULTS 
0 10 20 30 40 50 60 70 80 90 100 
TIME (min) 
3.1. mutagenesis of NEP cDiVA and expression of the 
mutated enzymes 
Site-directed mutagenesis of the NEP cDNA was 
used to substitute Gln or Phe for His7”, and these mu- 
tated cDNAs were introduced in the expression vector 
Fig. 1. Rate of hydrolyses of [tyrosyl-(3,5-~H)](~-Alan)-Leu-Enk~ph- 
ahn. The activity of non-mutated (6 ng) and mutated (6 ng) NEPs was 
determined by measuring the rate ofhydrolysis of ftyrosyl-(3,5-‘H)](D- 
Alaz)-Leu-Enkephalin (50 nM). The amounts of enzymes m the reac- 
tion mixtures were determined by immunoblot using known quanti- 
tites of purtfied kidney NEP as standards. 
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Table I 
Kinetic parameters of non-mutated and mutated NEPs 
Km cat k k,,,lKr,, MG 
(uM) (min-‘) (min-‘.pM-‘) (kcal.mol-‘) 
Non-mutated NEP 86 f 6 802 f 25 9.3 _ 
NEP-Gln7” 144f15 34f 2 0.24 2.25 
NEP-Phe”’ 125 f 16 31 f 2 0.25 2.23 
K,,, and k,,, values are the mean + S.D. of at least three separate 
determinations performed as described in section 2. Differences in free 
energy (MG) for mutated enzymes were calculated using the relation: -. 
Mb = -RT’ In((k,,,lK,),,,,d(k,,,lK 1 mnon mutant )I241 
3.3. Chemical mod@ication by DEPC 
It has been shown that NEP is sensitive to modifica- 
tion by DEPC, a compound reacting with histidine, 
tyrosine, arginine and lysine residues. From the kinetics 
of inhibition, it was postulated that a histidine residue 
in the active site of NEP was the target of DEPC [ 13,141. 
In order to verify that His”’ corresponds to the residue 
sensitive to DEPC, we proceeded to the modification of 
the non-mutated and mutated NEPs with this reagent. 
Thus, if His”’ is the unique target of DEPC in NEP 
active site, we would expect that the residual activity of 
mutants NEP-Gin”’ and NEP-Phe”’ will be insensitive 
to modification by this reagent. Surprisingly, mutants 
NEP-Gin”’ and NEP-Phe”’ were still sensitive to the 
action of DEPC (Fig. 2) albeit at a much reduced level. 
The IC,, values determined for non-mutated NEP, 
NEP-Gin”’ and NEP-Phe”’ were 50 f 7. 156 ? 12 and 
226 ? 24 ,LAI, respectively. 
4. DISCUSSION 
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Fig. 2. Inactivatton with diethylpyrocarbonate. Activity of non-mu- 
tated and mutated enzymes was determined by measuring the hydrol- 
ysis of [tyrosyl-(3,5-3H)](o-Ala,)-Leu-Enkephalin (50 nM) in the pres- 
ence of dtfferent concentrations of DEPC. 
could be crosslinked to iV-bromoacetyl-D-leucylglycine, 
an irreversible inhibitor of NEP which mimics the tran- 
sition state of the catalytic reaction [14]. This suggested 
that His”’ of NEP has a role similar to that of the His23’ 
of TLN. Interestingly, His”’ is located 65 residues from 
the zinc-coordinating residue, Glu%, in the NEP se- 
quence, and the same distance is observed between 
His23’ and G~u’~~ in the TLN sequence. Furthermore, 
Kim et al. [25] recently mutated all the histidine residues 
in the NEP sequence, except those involved in zinc liga- 
tion, and observed that only the mutation of His”’ 
abolished catalytic activity of the enzyme. However, 
since the enzymatic parameters for the mutated enzyme 
were not determined, it was impossible to evaluate the 
role of His”’ in catalysis. 
In the present study, we have used site-directed mut- 
agenesis to evaluate the role of His”’ of NEP in cataly- 
sis. Either Gln or Phe were substituted for His”’ of NEP 
and the kinetic parameters of the mutated enzymes were 
determined for both mutants. When measured under 
initial velocity conditions, both NEP-Gin”’ and NEP- 
Phe”’ showed 5% of the activity of non-mutated NEP, 
suggesting an important role for His”’ in enzyme activ- 
ity. However, this residual activity of mutant NEP- 
Gin”’ and NEP-Phe”’ was still sensitive to modifica- 
tion by DEPC. This result suggested either that His”’ 
is not the residue sensitive to DEPC modification, or 
that a second residue in or near the active site of NEP 
can also be modified by this reagent. 
It can be argued that replacing His”’ by either Gln 
or Phe disrupted the integrity of the active site of NEP, 
thus resulting in the lower activity observed. We believe 
this possibility to be improbable for the following rea- 
sons. Firstly, the K,,, values measured for the mutated 
enzymes are very similar to that determined for the 
non-mutated enzyme, thus suggesting that the sub- 
strate-binding subsites have been preserved. Secondly, 
the mutated and non-mutated enzymes showed similar 
IC,, for inhibition by the chelating agent, l-10 phenan- 
throline (results not shown). This result indicates that 
the zinc atom binds with similar affinity to the mutated 
and non-mutated enzymes and suggests that the geome- 
try of the ligands has not been grossly perturbed. 
Unlike the K,,, values, the k,,, values determined for 
the mutated enzymes were greatly reduced resulting in 
a calculated loss in binding energy (MG) of 2.2 kcal/ 
mol. This value is consistent with the loss of one hydro- 
gen bond in the tetrahedral intermediate [26]. The de- 
crease in activity observed for mutant NEPs is similar 
to that observed in Bacillus subtilis neutral protease, a 
protease homologous to TLN, bearing a His228-to-Leu 
mutation [27]. It was proposed that this decrease in 
activity was due to the loss of a hydrogen bond in the 
tetrahedral intermediate. Thus, these observations 
strongly suggest hat His”’ of NEP participates in the 
catalytic mechanism by forming a hydrogen bond with 
the oxyanion formed during the transition state, as does 
303 
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Hisz3’ in TLN [II], and further confirm the similarity 
between the catalytic mechanisms of NEP and TLN. 
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